/AMTI

AMTI Stock - Applied Molecular Transport Inc.

Q: What is the analyst price target for AMTI?

Analyst price target information is not currently available for AMTI.

Q: What is AMTI's market cap?

Market capitalization information is not currently available for AMTI.

Healthcare|Biotechnology|NASDAQ

$0.26-3.13%

$0.01 (-3.13%) • Dec 26

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

100

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+546.4%upside

Target: $1.70

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for AMTI

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2018

FY2019

FY2020

FY2021

FY2022

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta2.29

52W High$0.84

52W Low$0.13

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2022	FY2021	FY2020	FY2019	FY2018
Revenue	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A
Gross Margin	N/A	N/A	N/A	N/A	N/A
Operating Income	$-127,219,000	$-100,789,000	$-66,682,000	$-28,290,000	$-29,868,000
Net Income	$-125,431,000	$-96,410,000	$-64,493,000	$-28,043,000	$-29,868,000
Net Margin	N/A	N/A	N/A	N/A	N/A
EPS	$-3.23	$-2.56	$-2.82	$-1.31	$-1.70

Company Overview

Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trial for the treatment of ulcerative colitis and related inflammatory indications. It develops AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase I clinical trial for diseases related to intestinal epithelium barrier function defects. The company, through its technology platform, designs and develops various oral biologic therapeutic modalities, such as peptides, proteins, antibodies, antibody fragments, and ribonucleic acid therapeutics. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California.

Visit Website

Earnings History & Surprises

AMTI

Beat Rate

29%

Last 14 quarters

Avg Surprise

-30.8%

EPS vs Estimate

Beats / Misses

4/10

Last 12 quarters

Latest EPS

$-0.17

Q4 2023

EPS Surprise History

Q1 22

-23.8%

$-0.78vs$-0.63

Q2 22

-57.1%

$-1.10vs$-0.70

Q3 22

-43.1%

$-0.93vs$-0.65

Q4 22

+1.5%

$-0.65vs$-0.66

Q1 23

+12.1%

$-0.58vs$-0.66

Q2 23

-16.4%

$-0.71vs$-0.61

Q3 23

-157.1%

$-0.44vs$0.77

Q4 23

+66.0%

$-0.17vs$-0.50

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q4 2023	Nov 9, 2023	$-0.50	$-0.17	+66.0%	✓ BEAT
Q3 2023	Aug 14, 2023	$0.77	$-0.44	-157.1%	✗ MISS
Q2 2023	May 11, 2023	$-0.61	$-0.71	-16.4%	✗ MISS
Q1 2023	Mar 9, 2023	$-0.66	$-0.58	+12.1%	✓ BEAT
Q4 2022	Nov 7, 2022	$-0.66	$-0.65	+1.5%	✓ BEAT
Q3 2022	Aug 4, 2022	$-0.65	$-0.93	-43.1%	✗ MISS
Q2 2022	May 9, 2022	$-0.70	$-1.10	-57.1%	✗ MISS
Q1 2022	Feb 24, 2022	$-0.63	$-0.78	-23.8%	✗ MISS
Q4 2021	Nov 10, 2021	$-0.60	$-0.68	-13.3%	✗ MISS
Q3 2021	Aug 10, 2021	$-0.58	$-0.62	-6.9%	✗ MISS
Q2 2021	May 13, 2021	$-0.57	$-0.58	-1.8%	✗ MISS
Q1 2021	Mar 19, 2021	$-0.46	$-0.38	+17.4%	✓ BEAT
Q4 2020	Nov 12, 2020	$-0.41	$-0.48	-17.1%	✗ MISS
Q3 2020	Aug 11, 2020	$-0.38	$-1.11	-192.1%	✗ MISS
Q2 2020	May 18, 2020	—	$-0.49	—	—
Q2 2020	Apr 10, 2020	—	$-0.37	—	—
Q3 2019	Sep 30, 2019	—	$-0.37	—	—
Q2 2019	Jun 30, 2019	—	$-0.34	—	—
Q1 2019	Mar 31, 2019	—	$-0.23	—	—

Frequently Asked Questions about AMTI

What is AMTI's current stock price?

Applied Molecular Transport Inc. (AMTI) is currently trading at $0.26 per share. The stock has moved -3.13% today.

What is the analyst price target for AMTI?

The average analyst price target for AMTI is $1.70, based on 1 analyst.

What sector is Applied Molecular Transport Inc. in?

Applied Molecular Transport Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NASDAQ exchange.

What is AMTI's market cap?

Applied Molecular Transport Inc. has a market capitalization of $0.01 billion, making it a small-cap company.

Does AMTI pay dividends?

No, Applied Molecular Transport Inc. does not currently pay a dividend to shareholders.